A platform for research: civil engineering, architecture and urbanism
Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease
Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease
Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease
ANTIOXIDANTS AND REDOX SIGNALING ; 25 ; 61-77
2016-01-01
17 pages
Article (Journal)
English
DDC:
611
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
British Library Online Contents | 2016
British Library Online Contents | 2014
|British Library Online Contents | 2016